scorecardresearch
Tuesday, July 22, 2025
TopicBiocon

Topic: Biocon

India prepares to test Itolizumab, the drug credited for lowering Covid mortality in Cuba

The drug will go under trial in six hospitals in India, including AIIMS-Delhi, KEM Hospital in Mumbai and Narayana Health in Bengaluru. 

Biocon’s blood purification device gets regulator nod for treating critical Covid patients

CytoSorb was introduced in 2013 for Sepsis patients. It has now been allowed to treat critical Covid patients to help reduce their cytokines levels.

Made-in-India Covid-19 vaccine could be ready in a year, says Biocon’s Kiran Mazumdar-Shaw

In an interview to ThePrint, Biocon co-founder Kiran Mazumdar-Shaw says India is ahead of other countries in flattening the Covid-19 curve.

On Camera

Bihar mimics 19th-century American South. Citizenship is now weaponised to exclude voters

Disenfranchisement by institutional fiat is profoundly undemocratic. The effect of the ECI's new documentary process in Bihar will tilt the scales in favour of the BJP.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.